Literature DB >> 2566954

The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined by in situ hybridization.

M Savasta1, E Ruberte, J M Palacios, G Mengod.   

Abstract

The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs was studied with a cellular resolution in the mesencephalic dopaminergic neurons of the rat brain by in situ hybridization using synthetic oligonucleotides. An extensive colocalization of cholecystokinin-expressing cells, greater than that seen previously by immunohistochemistry, was found in the ventral tegmental area and in the substantia nigra pars compacta. We observed in these regions that cholecystokinin and tyrosine hydroxylase mRNAs coexisted in the same neurons but not all dopamine cells expressed cholecystokinin mRNA. 6-Hydroxydopamine-induced destruction of mesostriatal dopaminergic neurons resulted in a complete loss of cholecystokinin and tyrosine hydroxylase mRNA expression throughout the substantia nigra pars compacta, indicating that all cholecystokinin expressing cells are 6-hydroxydopamine-sensitive. While increased enkephalin mRNA expression in the striatum ipsilateral to the lesion was detected, no change of cholecystokinin mRNA expression was observed in any forebrain on the lesioned side, suggesting that cholecystokinin expression in the forebrain is not under dopaminergic control. These results show the usefulness of the in situ hybridization approach for the precise localization of cells in rat brain which express mRNAs for cholecystokinin and tyrosine hydroxylase and for the study of the effects of neurotoxic lesions on these cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566954     DOI: 10.1016/0306-4522(89)90063-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry.

Authors:  G Mengod; M I Martinez-Mir; M T Vilaró; J M Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

3.  The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.

Authors:  G Mengod; J L Charli; J M Palacios
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

4.  Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons.

Authors:  N Lindefors; S Brené; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

5.  Brain expression and song regulation of the cholecystokinin gene in the zebra finch (Taeniopygia guttata).

Authors:  Peter V Lovell; Claudio V Mello
Journal:  J Comp Neurol       Date:  2011-02-01       Impact factor: 3.215

6.  Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease.

Authors:  Sang J Na; Anthony G DiLella; Edward V Lis; Keith Jones; David M Levine; David J Stone; J F Hess
Journal:  Neurochem Res       Date:  2010-02-19       Impact factor: 3.996

7.  Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia.

Authors:  M Schalling; K Friberg; K Seroogy; P Riederer; E Bird; S N Schiffmann; P Mailleux; J J Vanderhaeghen; S Kuga; M Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration.

Authors:  S L Cottingham; D Pickar; T K Shimotake; P Montpied; S M Paul; J N Crawley
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.